<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">

<pmc-articleset><article article-type="research-article" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<!--The publisher of this article does not allow downloading of the full text in XML form.-->
<front>
<journal-meta>
<journal-id journal-id-type="nlm-ta">Innov Clin Neurosci</journal-id>
<journal-id journal-id-type="iso-abbrev">Innov Clin Neurosci</journal-id>
<journal-id journal-id-type="publisher-id">ICNS</journal-id>
<journal-title-group>
<journal-title>Innovations in Clinical Neuroscience</journal-title>
</journal-title-group>
<issn pub-type="ppub">2158-8333</issn>
<issn pub-type="epub">2158-8341</issn>
<publisher>
<publisher-name>Matrix Medical Communications</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">32082942</article-id>
<article-id pub-id-type="pmc">7006862</article-id>
<article-id pub-id-type="other">icns_16_11-12_36</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Study Protocol</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Placental Barrier and Autism Spectrum Disorders: The Roles of Prolactin and Dopamine in the Developing Fetal Brain—Part II</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author" corresp="yes">
<name>
<surname>Yarlagadda</surname>
<given-names>Atmaram</given-names>
</name>
<degrees>MD</degrees>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Acharya</surname>
<given-names>Ganesh</given-names>
</name>
<degrees>MD, PhD, FRCOG</degrees>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Kasaraneni</surname>
<given-names>Jayaprada</given-names>
</name>
<degrees>MBBS</degrees>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Hampe</surname>
<given-names>Christiane S.</given-names>
</name>
<degrees>PhD</degrees>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Clayton</surname>
<given-names>Anita H.</given-names>
</name>
<degrees>MD</degrees>
</contrib>
<aff>Dr. Yarlagadda is with the Department of Defense and the University of Virginia in Charlottesville, Virginia.</aff>
<aff>Dr. Acharya is with the Karolinska Institutet in Solna, Sweden.</aff>
<aff>Dr. Kasaraneni is with Texas Tech University in Lubbock, Texas.</aff>
<aff>Dr. Hampe is with the University of Washington in Seattle, Washington.</aff>
<aff>Dr. Clayton is with the University of Virginia in Charlottesville, Virginia.</aff>
</contrib-group>
<author-notes>
<corresp><bold>CORRESPONDENCE:</bold> Atmaram Yarlagadda, MD; Email: <email xlink:type="simple">atma@golfolks.com</email></corresp>
<fn fn-type="COI-statement">
<p><bold>FUNDING:</bold>No funding was provided.</p>
</fn>
<fn fn-type="COI-statement">
<p><bold>DISCLOSURES:</bold>The authors have no conflicts of interest relevant to the content of this article.</p>
</fn>
</author-notes>
<pub-date pub-type="ppub">
<day>01</day>
<month>11</month>
<year>2019</year>
</pub-date>
<pub-date pub-type="epub">
<season>Nov-Dec</season>
<year>2019</year>
</pub-date>
<volume>16</volume>
<issue>11-12</issue>
<fpage>36</fpage>
<lpage>39</lpage>
<permissions>
<copyright-statement>Copyright © 2019. Matrix Medical Communications. All rights reserved.</copyright-statement>
<copyright-year>2019</copyright-year>
</permissions>
<abstract>
<p>The inverse relationship between prolactin and dopamine is important in the context of treatment with antipsychotic medications in men and nonpregnant women with thought disorders. Likewise, increased levels of prolactin as confirmation of recent seizure and the reciprocal levels of prolactin and dopamine in both eclampsia (seizures) and pre-eclampsia might have significant potential effects on a growing fetus. In this article, we attempt to outline the influence of these associations on autism spectrum disorders (ASDs) in children born to mothers with established diagnoses of eclampsia and/or pre-eclampsia. Our previously published paper, “Placental Barrier and Autism Spectrum Disorders: The Role of Prolactin and Dopamine on the Developing Fetal Brain,” summarized evidence for dysregulated dopamine and prolactin levels in the etiology of ASDs and suggested a possible method for assessing whether such aberrations increase the risk of ASDs. The present paper as Part 2 expands on the published data that support this theory and proposes a study design to corroborate this hypothesis.</p>
</abstract>
<kwd-group>
<kwd>autism</kwd>
<kwd>dopamine</kwd>
<kwd>placenta</kwd>
<kwd>prolactin</kwd>
</kwd-group>
</article-meta>
</front>
</article>
</pmc-articleset>